The DOI matches its Crossref record.
Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections
Abstract
BACKGROUND: Foot infections are a major cause of morbidity in people with diabetes and the most common cause of diabetes-related hospitalization and lower extremity amputation. Staphylococcus aureus is by far the most frequent species isolated from these infections. In particular, methicillin-resistant S. aureus (MRSA) has emerged as a major clinical and epidemiological problem in hospitals. MRSA strains have the ability to be resistant to most β-lactam antibiotics, but also to a wide range of other antimicrobials, making infections difficult to manage and very costly to treat. To date, there are two fifth-generation cephalosporins generally efficacious against MRSA, ceftaroline and ceftobripole, sharing a similar spectrum. Biofilm formation is one of the most important virulence traits of S. aureus. Biofilm growth plays an important role during infection by providing defence against several antagonistic mechanisms. In this study, we analysed the antimicrobial susceptibility patterns of biofilm-producing S. aureus strains isolated from diabetic foot infections. The antibiotic minimum inhibitory concentration (MIC) was determined for ten antimicrobial compounds, along with the minimum biofilm inhibitory concentration (MBIC) and minimum biofilm eradication concentration (MBEC), followed by PCR identification of genetic determinants of biofilm production and antimicrobial resistance. RESULTS: Results demonstrate that very high concentrations of the most used antibiotics in treating diabetic foot infections (DFI) are required to inhibit S. aureus biofilms in vitro, which may explain why monotherapy with these agents frequently fails to eradicate biofilm infections. In fact, biofilms were resistant to antibiotics at concentrations 10-1000 times greater than the ones required to kill free-living or planktonic cells. The only antibiotics able to inhibit biofilm eradication on 50 % of isolates were ceftaroline and gentamicin. CONCLUSIONS: The results suggest that the antibiotic susceptibility patterns cannot be applied to biofilm established infections. Selection of antimicrobial therapy is a critical step in DFI and should aim at overcoming biofilm disease in order to optimize the outcomes of this complex pathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Biofilm-producing DFI strains S. aureus Z25.2 and P. aeruginosa Z25.1, co-isolated from the same diabetic foot ulcer in an epidemiological study on DFI microbiota conducted by us and fully characterized [33,34,35,36], were used.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 47
- Spichler A, Hurwitz BL, Armstrong DG, Lipsky BA. Microbiology of diabetic foot infections: from Louis Pasteur to “crime scene investigation.”. BMC Med. 2015;13:1–13. · DOI · Paper page
- Mendes JJ, Marques-Costa A, Vilela C, Neves J, Candeias N, Cavaco-Silva P, et al. Clinical and bacteriological survey of diabetic foot infections in Lisbon. Diabetes Res Clin Pract. 2012;95:153–61. · DOI · Paper page
- Lipsky BA, Richard J-L, Lavigne J-P. Diabetic foot ulcer microbiome: one small step for molecular microbiology … One giant leap for understanding diabetic foot ulcers? Diabetes. 2013;62:679–81. · DOI
- Petrelli D, Repetto A, D’Ercole S, Rombini S, Ripa S, Prenna M, et al. Analysis of meticillin-susceptible and meticillin-resistant biofilm-forming Staphylococcus aureus from catheter infections isolated in a large Italian hospital. J Med Microbiol. 2008;57:364–72. · DOI
- Rice LB. Antimicrobial resistance in gram-positive bacteria. Am J Infect Control. 2006;119:11–9. · DOI · Paper page
- Chan LC, Basuino L, Diep B, Hamilton S, Chatterjee SS, Chambers HF. Ceftobiprole- and ceftaroline-resistant methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2015;59:2960–3. · doi:10.1128/aac.05004-14
- Scherr TD, Heim CE, Morrison JM, Kielian T. Hiding in Plain Sight: Interplay between Staphylococcal Biofilms and Host Immunity. Front Immunol. 2014;5:1–7. · DOI · Paper page
- Gordon RJ, Lowy FD. Pathogenesis of methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis. 2008;46 Suppl 5:S350–9. · DOI · Paper page
- Lister JL, Horswill AR. Staphylococcus aureus biofilms: recent developments in biofilm dispersal. Front Cell Infect Microbiol. 2014;4:178. · DOI · Paper page
- Kaplan JB. Antibiotic-induced biofilm formation. Int J Artif Organs. 2011;34:737–51. · DOI · Paper page
- Rohde H, Burandt EC, Siemssen N, Frommelt L, Burdelski C, Wurster S, et al. Polysaccharide intercellular adhesin or protein factors in biofilm accumulation of Staphylococcus epidermidis and Staphylococcus aureus isolated from prosthetic hip and knee joint infections. Biomaterials. 2007;28:1711–20. · DOI · Paper page
- Biswas R, Voggu L, Simon UK, Hentschel P, Thumm G, Götz F. Activity of the major staphylococcal autolysin Atl. FEMS Microbiol Lett. 2006;259:260–8. · DOI · Paper page
- Hussain M, Schäfer D, Juuti KM, Peters G, Haslinger-Löffler B, Kuusela PI, et al. Expression of Pls (plasmin sensitive) in Staphylococcus aureus negative for pls reduces adherence and cellular invasion and acts by steric hindrance. J Infect Dis. 2009;200:107–17. · DOI
- Mottola C, Semedo-Lemsadeck T, Mendes JJ, Melo Cristino J, Cavaco Silva P, Tavares L, Oliveira M: Molecular typing, virulence traits and antimicrobial resistance of diabetic foot staphylococci. J Biomed Sci. 2016;23:33. · DOI · Paper page
- Ceri H, Olson M, Stremick C. The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol. 1999. · DOI · Paper page
- LaPlante KL, Mermel LA. In vitro activities of telavancin and vancomycin against biofilm-producing Staphylococcus aureus, S. epidermidis, and Enterococcus faecalis strains. Antimicrob Agents Chemother. 2009;53:3166–9. · DOI
- Pettit RK, Weber CA, Kean MJ, Hoffmann H, Pettit GR, Tan R, et al. Microplate Alamar blue assay for Staphylococcus epidermidis biofilm susceptibility testing. Antimicrob Agents. 2005;49:2612–7. · DOI · Paper page
- Cafiso V, Bertuccio T, Spina D, Purrello S, Stefani S. Tigecycline inhibition of a mature biofilm in clinical isolates of Staphylococcus aureus: comparison with other drugs. FEMS Immunol Med Microbiol. 2010;59:466–9. · doi:10.1111/j.1574-695x.2010.00701.x
- Coraça-Huber DC, Fille M, Hausdorfer J, Pfaller K, Nogler M. Staphylococcus aureus biofilm formation and antibiotic susceptibility tests on polystyrene and metal surfaces. J Appl Microbiol. 2012;112:1235–43. · doi:10.1111/j.1365-2672.2012.05288.x
- Pettit RK, Weber CA, Pettit GR. Application of a high throughput Alamar blue biofilm susceptibility assay to Staphylococcus aureus biofilms. Ann Clin Microbiol Antimicrob. 2009;8:28. · DOI
- Harrison JJ. Stremick C a, Turner RJ, Allan ND, Olson ME, Ceri H: Microtiter susceptibility testing of microbes growing on peg lids: a miniaturized biofilm model for high-throughput screening. Nat Protoc. 2010;5:1236–54. · DOI · Paper page
- Mottola C, Mendes JJ, Cristino JM, Cavaco-Silva P, Tavares L, Oliveira M. Polymicrobial biofilms by diabetic foot clinical isolates. Folia Microbiol (Praha). 2015;61 Suppl 1:35–43.
- Stegger M, Andersen PS, Kearns A, Pichon B, Holmes MA, Edwards G, et al. Rapid detection, differentiation and typing of methicillin-resistant Staphylococcus aureus harbouring either mecA or the new mecA homologue mecA LGA251. Clin Microbiol Infect. 2012;18:395–400. · DOI · Paper page
- Neut D. Tijdens-Creusen EJ a, Bulstra SK, van der Mei HC, Busscher HJ: Biofilms in chronic diabetic foot ulcers--a study of 2 cases. Acta Orthop. 2011;82:383–5. · DOI
- Savolainen K, Paulin L, Westerlund-wikstrom B, Foster T, Korhonen TK, Kuusela P. Expression of pls, a Gene Closely Associated with the mecA Gene of Methicillin-Resistant Staphylococcus aureus, Prevents Bacterial Adhesion In Vitro. Microbiology. 2001;69:3013–20.
- Patel R. Biofilms and Antimicrobial Resistance. Clin Orthop Relat Res. 2005;437:41–7. · DOI · Paper page
- Siripornmongcolchai T, Chomvarin C, Chaicumpar K, Limpaiboon T, Wongkhum C. Evaluation of different primers for detecting mecA gene by PCR in comparison with phenotypic methods for discrimination of methicillin-resistant Staphylococcus aureus. Southeast Asian J ournal Trop Med Public Heal. 2002;33:758–63.
- García-Álvarez L, Holden MTG, Lindsay H, Webb CR, Brown DFJ, Curran MD, et al. Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: A descriptive study. Lancet Infect Dis. 2011;11:595–603. · DOI · Paper page
- Paterson GK, Harrison EM. Holmes M a.: The emergence of mecC methicillin-resistant Staphylococcus aureus. Trends Microbiol. 2014;22:42–7. · DOI
- Bowling FL, Jude EB, Boulton AJM. MRSA and diabetic foot wounds: contaminating or infecting organisms? Curr Diab Rep. 2009;9:440–4. · DOI
- Djahmi N, Messad N, Nedjai S, Moussaoui A, Mazouz D, Richard J, et al. Molecular epidemiology of Staphylococcus aureus strains isolated from inpatients with infected diabetic foot ulcers in an Algerian University Hospital. Clin Microbiol Infect. 2013;19:E398–404. · DOI
- Pereira LA, Harnett GB, Hodge MM, Cattell JA, Speers DJ. Real-time PCR assay for detection of blaZ genes in Staphylococcus aureus clinical isolates. J Clin Microbiol. 2014;52:1259–61. · DOI
- El Feghaly RE, Stamm JE. Fritz S a., Burnham CAD: Presence of the blaZ beta-lactamase gene in isolates of Staphylococcus aureus that appear penicillin susceptible by conventional phenotypic methods. Diagn Microbiol Infect Dis. 2012;74:388–93. · DOI
- Barber KE, Smith JR, Ireland CE, Boles BR, Rose WE, Rybak MJ: Evaluation of Ceftaroline Alone and in Combination Against Biofilm-producing 1 Methicillin-resistant Staphylococcus aureus (MRSA) with Reduced Susceptibility to 2 daptomycin and vancomycin in an In Vitro Pharmacokinetic/Pharmacodynamic Model. Antimicrob Agents Chemother 2015(May). · DOI
- Barber KE, Werth BJ, McRoberts JP, Rybak MJ. A Novel Approach Utilizing Biofilm Time Kill Curves in Assessing the Bactericidal Activity of Ceftaroline Combinations Against Biofilm Producing Methicillin-Resistant Staphylococcus aureus (MRSA). Antimicrob Agents Chemother. 2014;58:2989–92. · DOI
- Kotulová D, Slobodníková L. Susceptibility of Staphylococcus aureus biofilms to vancomycin, gemtamicin and rifampin. Epidemiol Mikrobiol Imunol. 2010;59:80–7.
- Martineau F, Picard FJ, Lansac N, Ménard C, Roy PH, Ouellette M, et al. Correlation between the resistance genotype determined by multiplex PCR assays and the antibiotic susceptibility patterns of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother. 2000;44:231–8. · DOI · Paper page
- Smith K, Perez A, Ramage G, Gemmell CG, Lang S. Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin. Int J Antimicrob Agents. 2009;33:374–8. · DOI
- Rose WE, Poppens PT. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus. J Antimicrob Chemother. 2009;63:485–8. · DOI
- Strommenger B, Kettlitz C, Werner G. Multiplex PCR assay for simultaneous detection of nine clinically relevant antibiotic resistance genes in Staphylococcus aureus. J Clin Microbiol. 2003;41:4089–94. · DOI · Paper page
- Werner G, Cuny C, Schmitz F. Staphylococcus aureus with Reduced Sensitivity to Glycopeptides. J Clin Microbiol. 2001;39:3586–90. · DOI
- Jv S, Janakiram K, Vijaya D. Inducible clindamycin resistance in Staphylococcus aureus : Reason for treatment failure. J Int Med Dent. 2015;2:97–103. · doi:10.18320/jimd/201502.0297
- Andersen JL, He GX, Kakarla P, Ranjana KC, Kumar S, Lakra WS, et al. Multidrug efflux pumps from enterobacteriaceae, Vibrio cholerae and Staphylococcus aureus bacterial food pathogens. Int J Environ Res Public Health. 2015;12:1487–547. · DOI · Paper page
- Trzcinski K, Cooper BS, Hryniewicz W, Dowson CG. Expression of resistance to tetracyclines in strains of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother. 2000;45:763–70. · DOI · Paper page
- Arciola CR, Baldassarri L, Montanaro L. Presence of icaA and icaD genes and slime production in a collection of staphylococcal strains from catheter-associated infections. J Clin Microbiol. 2001;39:2151–6. · DOI · Paper page
- Ng LK, Martin I, Alfa M, Mulvey M. Multiplex PCR for the detection of tetracycline resistant genes. Mol Cell Probes. 2001;15:209–15. · DOI · Paper page
- Pourmand MR, Yousefi M, Salami SA, Amini M. Evaluation of Expression of NorA Efflux Pump in Ciprofloxacin Resistant Staphylococcus aureus against Hexahydroquinoline Derivative by Real-Time PCR. Acta Med Iran. 2014;52:424–9.
Cited by
Tolerance and resistance of microbial biofilms
Ciofu, O., Moser, C., Jensen, P. Ø., & Høiby, N. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00682-4 · Cited by 1,124
Del Pozo, J. L. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1417036 · Cited by 453
Serrano, I., Alhinho, B., Cunha, E., Tavares, L., Trindade, A., & Oliveira, M. (2023) · Life · doi:10.3390/life13020504 · Cited by 33
Self-citation
Metadata
- Authors
- Mottola, C., Matias, C. S., Mendes, J. J., Melo-Cristino, J., Tavares, L., Cavaco-Silva, P., & Oliveira, M.
- Venue
- BMC Microbiology
- Published
- 2016-06-23
- Volume
- 16
- Issue
- 1
- ISSN
- 1471-2180
- Cited by
- 118
- References
- 0
- Language
- en
- Funders
- Fundação para a Ciência e a Tecnologia (SFRH/BD/72872/2010)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections. https://app.cochat.ai/papers/10.1186/s12866-016-0737-0
- The paper
- Mottola, C., Matias, C. S., Mendes, J. J., Melo-Cristino, J., Tavares, L., Cavaco-Silva, P., & Oliveira, M. (2016). Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections. BMC Microbiology. https://doi.org/10.1186/s12866-016-0737-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.